Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer

NCT00408226 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Non-Small Cell Lung Cancer

Interventions

DRUG: MKC-1
DRUG: pemetrexed

Sponsor

CASI pharmaceuticals, Inc.